ES2170266T3 - Sistema matricial transdermico. - Google Patents
Sistema matricial transdermico.Info
- Publication number
- ES2170266T3 ES2170266T3 ES96932647T ES96932647T ES2170266T3 ES 2170266 T3 ES2170266 T3 ES 2170266T3 ES 96932647 T ES96932647 T ES 96932647T ES 96932647 T ES96932647 T ES 96932647T ES 2170266 T3 ES2170266 T3 ES 2170266T3
- Authority
- ES
- Spain
- Prior art keywords
- weight
- parts
- transdermal
- marriage
- rent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000005556 hormone Substances 0.000 abstract 2
- 229940088597 hormone Drugs 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 abstract 1
- WAHQVRCNDCHDIB-QZYSPNBYSA-N [(3s,8r,9s,10r,13s,14s,17r)-17-acetyl-17-acetyloxy-6,10,13-trimethyl-1,2,3,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-yl] 3-cyclopentylpropanoate Chemical compound O([C@@H]1C=C2C(C)=C[C@H]3[C@@H]4CC[C@]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)(OC(=O)C)C(C)=O)C(=O)CCC1CCCC1 WAHQVRCNDCHDIB-QZYSPNBYSA-N 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 abstract 1
- 229920001038 ethylene copolymer Polymers 0.000 abstract 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Telephonic Communication Services (AREA)
- Soy Sauces And Products Related Thereto (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UN NUEVO SISTEMA MATRICIAL TRANSDERMICO PARA LA ADMINISTRACION POR VIA PERCUTANEA DE UNA HORMONA. EL CITADO SISTEMA, QUE COMPRENDE UN SOPORTE Y UNA MATRIZ ADHESIVA, SE CARACTERIZA PORQUE DICHA MATRIZ COMPRENDE: (A) DE 39 A 61 PARTES EN PESO DE COPOLIMERO DE ETILENO Y DE ACETATO DE VINILO, (B) DE 12 A 17 PARTES EN PESO DE MIRISTATO DE 2 OCTILDODECIL, (C) DE 5 A 17 PARTES EN PESO DE FTALATO DE DIETILO, (D) DE 10 A 16 PARTES EN PESO DE UN COMPUESTO ELEGIDO ENTRE LAS N - ALQUIL - 2 - PIRROLIDONAS, EN LAS CUALES EL GRUPO ALQUILO ES UN GRUPO C 4 - C 15 , (E) DE 1 A 12 PARTES EN PESO DE AL MENOS UNA HORMONA ELEGIDA ENTRE EL CONJUNTO CONSTITUIDO POR LOS COMPONENTES ESTROGENICOS Y LOS COMPONENTES PROGESTAGENOS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DE ESTE SISTEMA MATRICIAL TRANSDERMICO Y A SU USO TERAPEUTICO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9511326A FR2739032B1 (fr) | 1995-09-27 | 1995-09-27 | Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2170266T3 true ES2170266T3 (es) | 2002-08-01 |
Family
ID=9482961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96932647T Expired - Lifetime ES2170266T3 (es) | 1995-09-27 | 1996-09-25 | Sistema matricial transdermico. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6013276A (es) |
| EP (1) | EP0852492B1 (es) |
| JP (1) | JPH11514988A (es) |
| KR (1) | KR19990063732A (es) |
| CN (1) | CN1083259C (es) |
| AT (1) | ATE209031T1 (es) |
| AU (1) | AU702542B2 (es) |
| BG (1) | BG102322A (es) |
| BR (1) | BR9610665A (es) |
| CA (1) | CA2233162A1 (es) |
| CZ (1) | CZ95398A3 (es) |
| DE (1) | DE69617252T2 (es) |
| DK (1) | DK0852492T3 (es) |
| EE (1) | EE9800082A (es) |
| ES (1) | ES2170266T3 (es) |
| FR (1) | FR2739032B1 (es) |
| HU (1) | HUP9900375A3 (es) |
| IL (1) | IL123594A0 (es) |
| NO (1) | NO981252D0 (es) |
| NZ (1) | NZ319181A (es) |
| PL (1) | PL325644A1 (es) |
| PT (1) | PT852492E (es) |
| SK (1) | SK282613B6 (es) |
| TR (1) | TR199800563T1 (es) |
| WO (1) | WO1997011687A1 (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10211832A1 (de) * | 2002-03-16 | 2003-10-02 | Lohmann Therapie Syst Lts | Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion |
| DE602004026173D1 (de) * | 2003-04-29 | 2010-05-06 | Gen Hospital Corp | Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US8633178B2 (en) | 2011-11-23 | 2014-01-21 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| EP3145489A1 (en) | 2014-05-22 | 2017-03-29 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3049628C2 (de) * | 1980-12-31 | 1982-10-21 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Überwachung des Entstehens und Fortschreitens von Rissen in Maschinenteilen und Bauteilen sowie eine Vorrichtung zur Durchführung des Verfahrens |
| JPS58189115A (ja) * | 1982-04-30 | 1983-11-04 | Kowa Co | 外用剤 |
| US4816258A (en) * | 1987-02-26 | 1989-03-28 | Alza Corporation | Transdermal contraceptive formulations |
| FR2612785A1 (fr) * | 1987-03-25 | 1988-09-30 | Lhd Lab Hygiene Dietetique | Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee |
| JPH03275619A (ja) * | 1990-03-23 | 1991-12-06 | Nitsusui Seiyaku Kk | 外用剤組成物 |
| US5286490A (en) * | 1990-05-04 | 1994-02-15 | Colgate-Palmolive Company | Transdermal fluoride medication |
| US5122382A (en) * | 1990-10-29 | 1992-06-16 | Alza Corporation | Transdermal contraceptive formulations, methods and devices |
| US5453279A (en) * | 1992-04-21 | 1995-09-26 | Tbs Laboratories, Inc. | Enhancing transdermal absorption compositions; transdermal dosage form; and process |
| FR2717688B1 (fr) * | 1994-03-28 | 1996-07-05 | Lhd Lab Hygiene Dietetique | Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA. |
-
1995
- 1995-09-27 FR FR9511326A patent/FR2739032B1/fr not_active Expired - Fee Related
-
1996
- 1996-09-25 CA CA002233162A patent/CA2233162A1/en not_active Abandoned
- 1996-09-25 JP JP9513181A patent/JPH11514988A/ja active Pending
- 1996-09-25 CZ CZ98953A patent/CZ95398A3/cs unknown
- 1996-09-25 NZ NZ319181A patent/NZ319181A/xx unknown
- 1996-09-25 HU HU9900375A patent/HUP9900375A3/hu unknown
- 1996-09-25 AU AU71349/96A patent/AU702542B2/en not_active Ceased
- 1996-09-25 CN CN96197187A patent/CN1083259C/zh not_active Expired - Fee Related
- 1996-09-25 BR BR9610665A patent/BR9610665A/pt not_active Application Discontinuation
- 1996-09-25 EP EP96932647A patent/EP0852492B1/fr not_active Expired - Lifetime
- 1996-09-25 PT PT96932647T patent/PT852492E/pt unknown
- 1996-09-25 EE EE9800082A patent/EE9800082A/xx unknown
- 1996-09-25 AT AT96932647T patent/ATE209031T1/de not_active IP Right Cessation
- 1996-09-25 DK DK96932647T patent/DK0852492T3/da active
- 1996-09-25 US US09/043,760 patent/US6013276A/en not_active Expired - Fee Related
- 1996-09-25 KR KR1019980702199A patent/KR19990063732A/ko not_active Withdrawn
- 1996-09-25 ES ES96932647T patent/ES2170266T3/es not_active Expired - Lifetime
- 1996-09-25 TR TR1998/00563T patent/TR199800563T1/xx unknown
- 1996-09-25 DE DE69617252T patent/DE69617252T2/de not_active Expired - Fee Related
- 1996-09-25 PL PL96325644A patent/PL325644A1/xx unknown
- 1996-09-25 IL IL12359496A patent/IL123594A0/xx not_active IP Right Cessation
- 1996-09-25 WO PCT/FR1996/001494 patent/WO1997011687A1/fr not_active Ceased
- 1996-09-25 SK SK406-98A patent/SK282613B6/sk unknown
-
1998
- 1998-03-12 BG BG102322A patent/BG102322A/xx unknown
- 1998-03-19 NO NO981252A patent/NO981252D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ95398A3 (cs) | 1998-07-15 |
| SK40698A3 (en) | 1998-09-09 |
| AU702542B2 (en) | 1999-02-25 |
| DE69617252T2 (de) | 2002-07-25 |
| CN1197390A (zh) | 1998-10-28 |
| WO1997011687A1 (fr) | 1997-04-03 |
| TR199800563T1 (xx) | 1998-06-22 |
| FR2739032A1 (fr) | 1997-03-28 |
| DK0852492T3 (da) | 2002-05-13 |
| US6013276A (en) | 2000-01-11 |
| CN1083259C (zh) | 2002-04-24 |
| NO981252L (no) | 1998-03-19 |
| BR9610665A (pt) | 1999-07-13 |
| NZ319181A (en) | 1998-10-28 |
| EP0852492B1 (fr) | 2001-11-21 |
| BG102322A (en) | 1998-10-30 |
| AU7134996A (en) | 1997-04-17 |
| PT852492E (pt) | 2002-05-31 |
| HUP9900375A3 (en) | 1999-11-29 |
| FR2739032B1 (fr) | 1997-11-21 |
| ATE209031T1 (de) | 2001-12-15 |
| JPH11514988A (ja) | 1999-12-21 |
| EP0852492A1 (fr) | 1998-07-15 |
| PL325644A1 (en) | 1998-08-03 |
| IL123594A0 (en) | 1998-10-30 |
| MX9802327A (es) | 1998-08-30 |
| DE69617252D1 (de) | 2002-01-03 |
| KR19990063732A (ko) | 1999-07-26 |
| NO981252D0 (no) | 1998-03-19 |
| HUP9900375A2 (hu) | 1999-06-28 |
| EE9800082A (et) | 1998-10-15 |
| SK282613B6 (sk) | 2002-10-08 |
| CA2233162A1 (en) | 1997-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2170266T3 (es) | Sistema matricial transdermico. | |
| ES2127484T3 (es) | Sistema matricial transdermico autoadhesivo para la administracion por via percutanea de una hormona. | |
| ES2163444T3 (es) | Composiciones y metodos para la administracion oral de farmacos. | |
| AR037181A1 (es) | Compuesto de 4-heteroaril-(5-miembros) acil pirrolidina, formulacion farmaceutica que lo comprende, uso del mismo para preparar un medicamento y procedimiento para su preparacion | |
| ECSP941122A (es) | Derivados de 5-arilindoles | |
| ES2125679T3 (es) | Sistema transdermico de administracion simultanea de varios principios activos. | |
| ES2167592T3 (es) | Preparaciones medicamentosas que contienen un enantiomero de bromuro de ipratropio con duracion de la accion prolongada. | |
| ES2174027T3 (es) | Composiciones estables que contienen macrolidos y macrolidos combinados con unas vacunas. | |
| ES2106029T3 (es) | Composiciones que mejoran la penetracion a traves de la piel. | |
| ATE288744T1 (de) | Arzneiformulierungen zur hormonersatztherapie zur topischen anwendung auf der haut | |
| MX9301929A (es) | Derivados de pirimidina y procedimientos para su preparacion. | |
| ES2088312T3 (es) | Formulacion de liberacion controlada que contiene tramadol. | |
| NO942525L (no) | Osmoseanordning med forsinket aktivering av medikamentavgivelse | |
| ES2128673T3 (es) | Sistema matricial transdermico de administracion de un estrogeno y/o un progestativo a base de copolimero estireno-isopreno-estireno. | |
| PT1077688E (pt) | Sistema terapeutico transdermico contendo pergolide | |
| ES2148178T3 (es) | Uso de derivados de sulfamato como inhibidores de esteroide-sulfatasa. | |
| NO981315L (no) | Transdermalt matrikssystem | |
| FI960556A0 (fi) | Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärjestelmä | |
| HRP20100254T1 (hr) | Transdermalni sustav za davanje gestodena | |
| SV1998000029A (es) | Compuestos de pirazina ref. pg3186 | |
| TR200201509T2 (tr) | Farmasötik olarak aktif benzazol türevleri. | |
| BR9709934A (pt) | Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga | |
| MX9301197A (es) | Derivados de indol. | |
| MX9204914A (es) | Nuevos derivados de isatinoxima, metodo para su preparacion y composicion farmaceutica que los comprende. | |
| MX9300399A (es) | Derivados heterotriciclicos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 852492 Country of ref document: ES |